688105.SS
688105.SS
CNE100004ZK3
NANJING VAZYME BIOTECH CO LTD
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.377.881.285 1.377.898.265
0.0%
Cost of Revenue 419.662.700 414.356.563
1.3%
Gross Profit 958.218.585 963.541.701
0.6%
994.034.560 1.019.096.595
2.5%
Operating Income -35.815.975 -55.554.894
35.5%
Pretax Income -37.707.201 -58.251.326
35.3%
Net Income Common Stockholders -16.613.336 -18.093.810
8.2%
-- --
--
-- --
--
ende